Menu
GeneBe

DDX41

DEAD-box helicase 41, the group of DEAD-box helicases|Spliceosomal C complex|Spliceosomal P complex

Basic information

Region (hg38): 5:177511576-177516961

Links

ENSG00000183258NCBI:51428OMIM:608170HGNC:18674Uniprot:Q9UJV9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • DDX41-related hematologic malignancy predisposition syndrome (Strong), mode of inheritance: AD
  • DDX41-related hematologic malignancy predisposition syndrome (Strong), mode of inheritance: AD
  • DDX41-related hematologic malignancy predisposition syndrome (Definitive), mode of inheritance: AD
  • DDX41-related hematologic malignancy predisposition syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Familial myeloproliferative/lymphoproliferative neoplasms, multiple types, susceptibility toADOncologicAmong other findings, individuals have been described with hematologic malignancies, and awareness may allow early detection and managementAllergy/Immunology/Infectious; Oncologic25920683; 26712909

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DDX41 gene.

  • not provided (284 variants)
  • DDX41-related hematologic malignancy predisposition syndrome (95 variants)
  • not specified (60 variants)
  • DDX41-related condition (14 variants)
  • Inborn genetic diseases (14 variants)
  • Bone marrow hypocellularity (3 variants)
  • Acute myeloid leukemia (3 variants)
  • Myelodysplasia (2 variants)
  • - (2 variants)
  • Inherited acute myeloid leukemia (1 variants)
  • Myelodysplastic syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DDX41 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
14
clinvar
40
clinvar
5
clinvar
59
missense
7
clinvar
139
clinvar
1
clinvar
147
nonsense
10
clinvar
5
clinvar
15
start loss
1
clinvar
1
clinvar
2
frameshift
11
clinvar
9
clinvar
20
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
6
clinvar
7
splice region
1
12
9
5
27
non coding
1
clinvar
8
clinvar
35
clinvar
17
clinvar
61
Total 23 30 161 76 22

Highest pathogenic variant AF is 0.0000658

Variants in DDX41

This is a list of pathogenic ClinVar variants found in the DDX41 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-177511597-T-C not specified Uncertain significance (Apr 20, 2020)1336923
5-177511610-G-C not specified Uncertain significance (Apr 03, 2018)1336614
5-177511694-G-A Likely benign (Mar 27, 2019)1205457
5-177511717-G-A not specified Benign/Likely benign (Jun 21, 2019)434911
5-177511728-A-G not specified Uncertain significance (Oct 24, 2019)1337429
5-177511788-G-A not specified • DDX41-related disorder Benign/Likely benign (Apr 22, 2022)1196326
5-177511790-C-T DDX41-related disorder Likely benign (Jan 30, 2023)3054698
5-177511792-C-T Uncertain significance (Dec 04, 2022)2811517
5-177511806-G-A Likely benign (Sep 22, 2023)2877539
5-177511810-T-C DDX41-related disorder • DDX41-related hematologic malignancy predisposition syndrome Uncertain significance (Jun 09, 2023)2629530
5-177511824-C-T Likely benign (Oct 09, 2023)2762106
5-177511832-C-T Uncertain significance (Sep 21, 2022)2446223
5-177511833-G-A not specified Likely benign (Nov 25, 2023)1337686
5-177511866-G-A Likely benign (Jul 17, 2023)2958373
5-177511871-T-C Uncertain significance (Sep 23, 2022)1720235
5-177511901-C-A DDX41-related hematologic malignancy predisposition syndrome Uncertain significance (Dec 22, 2020)2500224
5-177511905-G-A Likely benign (Sep 15, 2022)2186096
5-177511920-G-A Likely benign (Jul 17, 2023)2969582
5-177511921-C-T Uncertain significance (Aug 09, 2023)2442413
5-177511930-G-A Uncertain significance (Jan 24, 2024)1980118
5-177511943-CA-C Likely benign (Apr 25, 2023)2992817
5-177511943-CAG-C Likely benign (Dec 06, 2023)1908592
5-177511947-G-A Likely benign (Mar 21, 2023)2792789
5-177512050-T-C Benign (Apr 03, 2019)1240812
5-177512077-G-T Benign (Sep 27, 2023)1896836

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DDX41protein_codingprotein_codingENST00000507955 175893
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.59e-80.9981256590891257480.000354
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.282724010.6790.00002534056
Missense in Polyphen67112.950.593171189
Synonymous-2.771991551.280.00001021201
Loss of Function2.811836.30.4960.00000190408

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005470.000547
Ashkenazi Jewish0.000.00
East Asian0.0005440.000544
Finnish0.000.00
European (Non-Finnish)0.0004810.000466
Middle Eastern0.0005440.000544
South Asian0.0003270.000327
Other0.0008160.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable ATP-dependent RNA helicase. Is required during post-transcriptional gene expression. May be involved in pre-mRNA splicing. {ECO:0000269|PubMed:25920683}.;
Disease
DISEASE: Myeloproliferative/lymphoproliferative neoplasms, familial (MPLPF) [MIM:616871]: A familial cancer predisposition syndrome with incomplete penetrance, characterized by increased susceptibility to myeloid neoplasms and rarely to lymphoid malignancies. MPLPF inheritance is autosomal dominant. {ECO:0000269|PubMed:25920683, ECO:0000269|PubMed:26712909}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
STING mediated induction of host immune responses;Regulation of innate immune responses to cytosolic DNA;Innate Immune System;Immune System;IRF3-mediated induction of type I IFN;Cytosolic sensors of pathogen-associated DNA (Consensus)

Recessive Scores

pRec
0.258

Intolerance Scores

loftool
rvis_EVS
-1.09
rvis_percentile_EVS
7.05

Haploinsufficiency Scores

pHI
0.225
hipred
Y
hipred_score
0.603
ghis
0.638

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.733

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ddx41
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
ddx41
Affected structure
positive regulation of NIK/NF-kappaB signaling
Phenotype tag
abnormal
Phenotype quality
disrupted

Gene ontology

Biological process
mRNA splicing, via spliceosome;apoptotic process;cell population proliferation;cell differentiation;positive regulation of type I interferon production;cellular response to interferon-beta;positive regulation of transcription by RNA polymerase II;defense response to virus
Cellular component
nucleus;spliceosomal complex;endoplasmic reticulum;cytosol;membrane;catalytic step 2 spliceosome
Molecular function
DNA binding;RNA binding;helicase activity;protein binding;ATP binding;metal ion binding